Phase 2 IC14 for Treatment of Amyotrophic Lateral Sclerosis

Conditions:   Amyotrophic Lateral Sclerosis;   Motor Neuron Disease Intervention:   Biological: IC14 Sponsor:   Implicit Bioscience Not yet recruiting

Source: ClinicalTrials.gov - April 25, 2018 Category: Research Source Type: clinical trials